Skip to Content

A Comprehensive Board Review in Hematology and Medical Oncology 2014

September 8-13, 2014

Robert C. Hickey Auditorium
Floor 11, R. Lee Clark Clinic, 1515 Holcombe Boulevard
The University of Texas MD Anderson Cancer Center
Houston, Texas

September 8-12, 2014:
Solid Tumors and Malignant Hematology

September 11-13, 2014:
Malignant and Benign Hematology

General Information

Goal

The course is a 6-day comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. The course is designed with breadth and depth sufficient to enable the participant to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be included.

Educational Objectives

At the conclusion of this educational activity, participants should be able to

  • Apply knowledge gained to prepare for the hematology and medical oncology subspecialty and recertification examinations in hematology and medical oncology (Knowledge, Competence);
  • Utilize current standards of care for patients with cancer, blood disorders and malignancies (Knowledge, Competence, Performance);
  • Demonstrate proficiency of knowledge in hematology and medical oncology (Knowledge, Competence, Performance);
  • Incorporate recent advances in management of hematologic and oncologic patients (Knowledge, Competence, Performance); and
  • Define molecular determinants of cancer risk and apply this knowledge in practice (Knowledge, Competence, Performance)

Target Audience

This program should be of interest to physicians, medical hematologists and oncologists, APNs, physician assistants and nurses.

Educational Methods

  • Lectures
  • Case-based Question-and-Answer Sessions (in board examination format)
  • Syllabi (hard copy and CD-ROM)
  • A/V USB flash drive recording of conference proceeding.  The A/V USB flash drive recording of conference proceedings will be mailed to all registered conference participants approximately 2 weeks after the conference.

The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

Evaluation

A course evaluation form will provide participants with the opportunity to review each session and speaker, to identify future educational needs, and to comment on any perceived commercial bias in the presentations.

Accreditation/Credit Designation

The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 49.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Certificates and Attendance Verification Certificates

Certificates awarding AMA PRA Category 1 Credit™ or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form.

Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.


© 2015 The University of Texas MD Anderson Cancer Center